IVDR at NeoGenomics
With the recent application of IVDR on May 26, 2022, there are new regulatory standards that oversee the sales and use of IVDs for the EU.
Written By:

James Yen
NeoGenomics Lab Operations | Hurricane Ian
Important Announcement
NeoGenomics Lab Operations | Hurricane Ian
Orphan CDx assays
Drug development is rapidly outpacing our ability to bring companion diagnostics to market.
MultiOmyx 101: An Introduction to Multiplexing Technology
Cancer claims more than half a million lives each year in the United States alone.
Written By:

Anna Juncker-Jensen
Comprehensive Genomic Profiling (CGP) expands precision medicine’s utility
With the first TKI therapy Imatinib (Gleevec) targeting the fusion BCR-ABL1, approved by FDA in 2001, we have witnessed the birth of modern targeted therapy and personalized medicine.
Written By:

Qinqin Zha
NeoGenomics will be exhibiting at the 2022 ASCO Annual Meeting from June 4 – 6
NeoGenomics will be exhibiting at the 2022 ASCO Annual Meeting from June 4 – 6, 2022.
Diagnostic Symposium
Join NeoGenomics for our upcoming Diagnostic Symposium on Tuesday, May 10, 9 to 10 a.m. PT.